These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 16334203)
1. [Any splanchnic vein thrombosis must make look for a forme fruste of myeloproliferative disorder]. Casadevall N; Valla D Rev Prat; 2005 Oct; 55(15):1669-70. PubMed ID: 16334203 [No Abstract] [Full Text] [Related]
2. The role of thrombophilia in splanchnic vein thrombosis. Primignani M; Mannucci PM Semin Liver Dis; 2008 Aug; 28(3):293-301. PubMed ID: 18814082 [TBL] [Abstract][Full Text] [Related]
3. Budd-Chiari syndrome and portal vein thrombosis associated with myeloproliferative disorders: diagnosis and management. Brière JB Semin Thromb Hemost; 2006 Apr; 32(3):208-18. PubMed ID: 16673275 [TBL] [Abstract][Full Text] [Related]
4. [Portal vein thrombosis as an onset form of silent myeloproliferative chronic syndrome]. Santaeugenia S; Martí S; Maria Ribera J; Millá F Med Clin (Barc); 2006 Oct; 127(15):598-9. PubMed ID: 17145021 [No Abstract] [Full Text] [Related]
5. Distinct clinical, laboratory and molecular features of myeloproliferative neoplasm patients with splanchnic vein thrombosis. How J; Trinkaus KM; Oh ST Br J Haematol; 2018 Oct; 183(2):310-313. PubMed ID: 29048104 [No Abstract] [Full Text] [Related]
6. Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes myeloprolifératifs. Galtier J; Drevon L; Le Bris Y; Giraudier S; Wemeau M; Legros L; Paz DL; Girodon F; Kiladjian JJ; Mesguich C; Parrens M; Mediavilla C; Roy L; Guy A; Mansier O; Ianotto JC; James C Haematologica; 2024 Jun; 109(6):1989-1993. PubMed ID: 38328854 [No Abstract] [Full Text] [Related]
7. Molecular analyses in the diagnosis of myeloproliferative neoplasm-related splanchnic vein thrombosis. Iurlo A; Cattaneo D; Gianelli U; Fermo E; Augello C; Cortelezzi A Ann Hematol; 2015 May; 94(5):881-2. PubMed ID: 25377046 [No Abstract] [Full Text] [Related]
8. A case of idiopathic portal vein thrombosis? Johnston RD; Chang C; Singh RK; Austin A; El-Omar E Gut; 2010 Jan; 59(1):111. PubMed ID: 20007958 [No Abstract] [Full Text] [Related]
9. Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis. Chait Y; Condat B; Cazals-Hatem D; Rufat P; Atmani S; Chaoui D; Guilmin F; Kiladjian JJ; Plessier A; Denninger MH; Casadevall N; Valla D; Brière JB Br J Haematol; 2005 May; 129(4):553-60. PubMed ID: 15877740 [TBL] [Abstract][Full Text] [Related]
10. Recurrent venous thrombosis: the sole manifestation of an occult myeloproliferative disease. Lang R; Inbal A; Jutrin I; Ravid M Isr J Med Sci; 1982 Jun; 18(6):705-7. PubMed ID: 7107208 [TBL] [Abstract][Full Text] [Related]
11. Acquired and inherited risk factors for splanchnic venous thrombosis. De Stefano V; Teofili L; Leone G Blood; 2001 May; 97(10):3314-5. PubMed ID: 11368062 [No Abstract] [Full Text] [Related]
12. Splanchnic vein thrombosis in myeloproliferative neoplasms: treatment algorithm 2018. Finazzi G; De Stefano V; Barbui T Blood Cancer J; 2018 Jun; 8(7):64. PubMed ID: 29946154 [TBL] [Abstract][Full Text] [Related]